Clinical Trials Browser

Active not recruiting × Advanced Rare Tumours × 90 days × Clear all

NCT01396408 2026-03-27

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

Phase 2 Active not recruiting

Advanced Rare Tumours